Lingohr Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Lingohr Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$202K	Sell	10,000 -8,000	-44%	-$141K	0.35%	93
2025 Q2	$302K	Sell	18,000 -197,159	-92%	-$3.18M	0.55%	63
2025 Q1	$3.31M	Buy	+215,159	New	+$3.84M	0.83%	59
2013 Q3	–	Sell	-65,600	Closed	-$2.57M	–	141
2013 Q2	$2.57M	Buy	+65,600	New	+$2.55M	0.48%	78

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Lingohr Asset Management's TEVA Position: Q3 2025 in Review

Lingohr Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 44% in Q3 2025, selling an estimated $141K and leaving 10,000 shares worth $202K. The position accounts for 0.35% of the portfolio, ranked #93.

Lingohr Asset Management first reported a position in TEVA in Q2 2013 and has held it in 4 quarters since. The position peaked at $3.31M in Q1 2025. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

Lingohr Asset Management held 10,000 shares of Teva Pharmaceuticals worth $202K as of Q3 2025.
Lingohr Asset Management sold 8,000 Teva Pharmaceuticals shares in Q3 2025, an estimated $141K.
Teva Pharmaceuticals made up 0.35% of Lingohr Asset Management's portfolio in Q3 2025, its #93 holding.
Lingohr Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
Lingohr Asset Management's Teva Pharmaceuticals position peaked at $3.31M in Q1 2025.
550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Lingohr Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.